Richard Gorlick, MD

Richard Gorlick, MD, discusses the challenges of identifying immunotherapeutic targets in osteosarcomas.

Richard Gorlick, MD, discusses the potential of antibody-drug conjugates in patients with osteosarcoma.

Richard Gorlick, MD, highlights methods for identifying immunotherapeutic targets in osteosarcomas.

Richard Gorlick, MD, discussed results from a study examining the use of integrative surfaceome profiling to identify immunotherapeutic targets in patients with osteosarcomas.